ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,321.41
0.25%
Dow Jones
39,872.99
0.17%
US Dollar vs MXN
16.60195
-0.12%
Brent Oil
82.135
-0.38%
Bitcoin
69,967.41
-0.23%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Bio Path Holdings Inc (BPTH)

  7. Bio Path Holdings Inc (BPTH) Noticias

BPTH

Bio Path (BPTH)

Bio Path Holdings Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:BPTH
FechaHoraFuenteTítuloSímboloCompañía
15/05/202406:50IH Market NewsU.S. Index Futures Flat Ahead of April CPI Data Release, Oil Prices DropNASDAQ:BPTHBio Path Holdings Inc
15/05/202406:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
15/05/202406:00GlobeNewswire Inc.Bio-Path Holdings Reports First Quarter 2024 Financial ResultsNASDAQ:BPTHBio Path Holdings Inc
14/05/202415:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BPTHBio Path Holdings Inc
08/05/202406:00GlobeNewswire Inc.Bio-Path Holdings to Announce First Quarter 2024 Financial Results on May 15, 2024NASDAQ:BPTHBio Path Holdings Inc
19/04/202411:14GlobeNewswire Inc.Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:BPTHBio Path Holdings Inc
18/04/202412:57GlobeNewswire Inc.Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:BPTHBio Path Holdings Inc
18/04/202406:00GlobeNewswire Inc.Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) PatientsNASDAQ:BPTHBio Path Holdings Inc
15/04/202406:00GlobeNewswire Inc.Bio-Path Holdings Expands Global Patent PortfolioNASDAQ:BPTHBio Path Holdings Inc
02/04/202406:00GlobeNewswire Inc.Bio-Path Holdings Provides 2024 Clinical and Operational UpdateNASDAQ:BPTHBio Path Holdings Inc
08/03/202416:11Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:BPTHBio Path Holdings Inc
08/03/202406:00GlobeNewswire Inc.Bio-Path Holdings Reports Full Year 2023 Financial ResultsNASDAQ:BPTHBio Path Holdings Inc
08/03/202405:22IH Market NewsU.S. Index Futures Fluctuate Ahead of Key Jobs Report; Oil Prices DipNASDAQ:BPTHBio Path Holdings Inc
07/03/202415:21Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:BPTHBio Path Holdings Inc
01/03/202406:00GlobeNewswire Inc.Bio-Path Holdings to Announce Fourth Quarter and Full Year 2023 Financial Results on March 8, 2024NASDAQ:BPTHBio Path Holdings Inc
29/02/202405:00Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:BPTHBio Path Holdings Inc
21/02/202406:00GlobeNewswire Inc.Bio-Path Holdings Announces 1-for-20 Reverse Stock SplitNASDAQ:BPTHBio Path Holdings Inc
02/02/202415:39Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BPTHBio Path Holdings Inc
23/01/202415:51Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BPTHBio Path Holdings Inc
17/01/202415:52Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BPTHBio Path Holdings Inc
10/01/202406:00GlobeNewswire Inc.Bio-Path Holdings Announces Completion of First Dose Cohort in Phase 1 Clinical Trial Evaluating BP1002 to Treat Refractory/Relapsed Lymphoma and Refractory/Relapsed Chronic Lymphocytic Leukemia PatientsNASDAQ:BPTHBio Path Holdings Inc
04/01/202416:18Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BPTHBio Path Holdings Inc
22/12/202315:06Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BPTHBio Path Holdings Inc
14/12/202306:00GlobeNewswire Inc.Bio-Path Holdings Successfully Completes First Dose Cohort of Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid LeukemiaNASDAQ:BPTHBio Path Holdings Inc
15/11/202306:00GlobeNewswire Inc.Bio-Path Holdings Reports Third Quarter 2023 Financial ResultsNASDAQ:BPTHBio Path Holdings Inc
08/11/202306:00GlobeNewswire Inc.Bio-Path Holdings to Announce Third Quarter 2023 Financial Results on November 15, 2023NASDAQ:BPTHBio Path Holdings Inc
24/10/202306:00GlobeNewswire Inc.Bio-Path Holdings to Host Virtual Key Opinion Leader Event to Discuss Prexigebersen and Advances in the Treatment Landscape for Acute Myeloid LeukemiaNASDAQ:BPTHBio Path Holdings Inc
08/09/202315:01GlobeNewswire Inc.Bio-Path Holdings to Present at H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:BPTHBio Path Holdings Inc
15/08/202306:00GlobeNewswire Inc.Bio-Path Holdings Reports Second Quarter 2023 Financial ResultsNASDAQ:BPTHBio Path Holdings Inc
08/08/202306:00GlobeNewswire Inc.Bio-Path Holdings to Announce Second Quarter 2023 Financial Results on August 15, 2023NASDAQ:BPTHBio Path Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:BPTH

Su Consulta Reciente

NYSE
XOM
Exxon Mobil
COIN
BTCUSD
Bitcoin
USOTC
RHHBY
Roche (QX)
NASDAQ
MSFT
Microsoft
CCOM
SILVER
SILVER
USOTC
ADDYY
Adidas (QX)
CCOM
US30
US 30
COIN
ETHUSD
Ethereum
NYSE
MCD
McDonalds
NASDAQ
GOOGL
Alphabet
FX
EURMXN
Euro vs MXN
NYSE
KO
Coca Cola
NYSE
CVX
Chevron
SPI
SP500
S&P 500
AMEX
XLF
Financial Select Sector
NASDAQ
TSLA
Tesla
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados